GSK Boronia Site Redevelopment – Industry Reference Group (IRG)
Posted: 14 September In June 2022, the Department of Jobs, Precincts and Regions (the department) invited BioMelbourne Network to join an Industry Reference Group (IRG) to help contribute to discussions to support potential options for the GSK Boronia…
Global pandemic therapeutics centre announced in Melbourne
Posted: 13 September Creating a second shield to protect humanity from future pandemics is the principal objective of a new global medical research centre being created in Melbourne. Greater resilience for societies around the world in dealing with…
Nutromics raises US$14 million for its ground-breaking wearable diagnostic platform
Posted: 8 September 2022 Melbourne, Australia & San Diego, USA: Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics’ continued expansion across Australia and…
Reforms to the Australian Research Council
Posted: 7 September Following on from the controversy surrounding ARC grants last year, the new Government has acted on its election promises to change the way the ARC operates. Education Minister Jason Clare has today announced a review…
ANDHealth Announces Partnership with Victorian Government
Posted: 7 September ANDHealth, Australia’s leading digital health commercialisation organisation, in partnership with the Victorian Government, today announced it has received $2.4M from the Australian Medtech Manufacturing Centre and Biotechnology Fund to create the Victorian Connected Health Innovation…
Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma
Posted: 6 September 2022 Expansion of the efti clinical development pipeline with a new Phase II setting Efti Phase II trial awarded €1.5M (~A$2.2M) in funding as part of the Polish Medical Research Agency program funded by the…
Luina Bio Acquisition Announcement
Posted: 1 September 2022 Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding Company as AcuraBio Brisbane, Australia – 31 August 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been…
Cloud Based Computing Services – What are the risk management and legal issues for users? – Stephens Lawyers & Consultants
Posted: 30 August 2022 Cloud services can be enablers for a company’s digital transformation. However, understanding the risks and legal issues associated with using cloud services is critical for risk management and protection of an organisation’s data and IP and to…
New Research Grant For Deoxymabs in Metastatic Breast Cancer (Patrys)
Posted: 26 August 2022 Today Patrys announced that the Olivia Newton-John Cancer Research Institute (ONJCRI) has been awarded a $100,000 Victorian State Government Victorian Medical Research Acceleration Fund (VMRAF) grant to support its research investigating the potential for PAT-DX1…
Have your say into a new scale-up and manufacturing facility for biotech and medtech companies
Posted: 25 August 2022 Closing date: 31 August 2022 Translational Manufacturing@TRI (TM@TRI) will serve as Australia’s first purpose built biomedical translational manufacturing facility that will enable biotech and medtech start-up companies to move to the scale-up stage. Construction…
BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
Posted: 24 August 2022 The Directors of Biotron Limited (‘Biotron’ or ‘the Company’) are pleased to advise that a Phase 2 HIV-1 clinical trial (BIT225-010; ACTRN12621000937819) of its lead antiviral drug, BIT225, is fully recruited. The trial, which…
CLARITY 2.0 COVID-19 Study Concludes Recruitment
Posted: 18 August 2022 Dimerix Limited (ASX: DXB) a biopharmaceutical company with Phase 3 clinical studies in inflammatory diseases currently underway, today confirmed that the CLARITY 2.0 led study of COVID-19 patients has concluded recruitment to allow this…
